FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine. Described is a pharmaceutical aerosol formulation for use in the administration of medicaments by inhalation, comprising beclometasone dipropionate and a formoterol salt for use in pressurised metered dose inhalers (pMDI's) at certain ratios. Metered dose inhaler and the use of beclomethasone dipropionate in a pharmaceutical aerosol formulation are also described.
EFFECT: co-administration of formoterol fumarate and beclometasone dipropionate by pressurised metered dose inhalers (pMDI's) provides significant advantages in the treatment and control of asthma.
23 cl, 1 dwg, 9 ex, 1 tbl
